Thank you, Mr. Chair.
My opening remarks will be brief because I'm sure committee members will have plenty of questions for me.
In the last few weeks, we have released a number of reports, notably on a universal drug plan, on the potential return on investment on electric vehicle car battery plants and on our economic and fiscal outlook. I assume that you and your colleagues will have questions on these reports, but I'm happy to take questions on these or any other topics.